Latest Entry: Louisiana Purchased by Reid     Latest Comments: Talk Back Here

« Transparency? What transparency? | Main | Dems living in alternative universe - claim health care process is transparent »

October 21, 2009

Britain's cost-effectiveness watchdog to cancer sufferers: 'No life-extending drugs for you'

Topics: Political News and commentaries

Just as is expected under Obamacare (Obama even admitted to rationing), Britain's cost-effectiveness watchdog - The National Institute for Health Clinical Excellence (NICE), has blocked the use of a life-extending breast cancer drug on the NHS, despite a fresh review of the medicine saying that it still did not feel GlaxoSmithKline's drug Tyverb was a cost-effective use of resources. NICE's action will result in 2,000 British women a year being denied access to the drug.

This story is not unlike what we've seen in Oregon through it's socialized medicine plan where a woman was denied cancer drug but offered assisted suicide because it was cheaper for her to die than to pay for a drug to save her life.

Posted by Abdul at October 21, 2009 10:21 AM



Articles Related to Political News and commentaries: